Drawing for BEPANTHEN

USPTO serial 90197581

BEPANTHEN

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
PERRY, KIMBERLY B
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with BEPANTHEN?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Sondra Schol

Sondra Schol BAYER U.S. LLC800 NORTH LINDBERGH BLVD.E2NAST. LOUIS, MO 63167

Goods and services

ClassDescriptionStatusFirst use
003Non-medicated cosmetic preparations in topical form for the treatment of eye conditions namely eye washes; and also including non-medicated skin care preparations for baby and maternity skin care, wound and scar care and allergic or dry skin irritations, specifically excluding any kind or type of hair care, hair styling, depilatory or hair colorant productsACTIVE—
005pharmaceutical preparations for skin care; pharmaceutical preparations for treating skin disorders; pharmaceutical preparations for the treatment of damaged skin and tissue, namely, preparations for protection from eczema and allergens and for the support of wound healing; pharmaceutical preparations, namely, medicated topical gels, creams, lotions, and sprays for the prevention and treatment of scars; pharmaceutical preparations, namely, medicated topical gels, creams, lotions, and sprays for the treatment of the skin, specifically prevention and treatment of dryness, redness, sunburn, tension and itching; pharmaceutical preparations, namely, medicated topical gels, creams, lotions, and sprays for protection against germs and bacteria; pharmaceutical preparations, namely, eye drops and medicated sprays for protection and treatment of dry and inflamed nasal mucosa and irritated eyes and the skin around them; pharmaceutical preparations, namely, medicated topical gels, creams, lotions, and sprays for the treatment of nappy rash, minor burns, minor wounds, dry nose; pharmaceutical preparations, namely, medicated topical gels, creams, lotions, and sprays for the treatment of eye and nose disorders and conditions; and eye dropsACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Dec 16, 2024MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Dec 16, 2024ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Apr 11, 2024EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 10, 2024EX5GSOU EXTENSION 5 GRANTED—
Apr 10, 2024EXT5SOU EXTENSION 5 FILED—
Apr 10, 2024EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 21, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 19, 2023EX4GSOU EXTENSION 4 GRANTED—
Oct 19, 2023EXT4SOU EXTENSION 4 FILED—
Oct 19, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 13, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 11, 2023EX3GSOU EXTENSION 3 GRANTED—
Apr 11, 2023EXT3SOU EXTENSION 3 FILED—
Apr 11, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 12, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Oct 10, 2022EX2GSOU EXTENSION 2 GRANTED—
Oct 10, 2022EXT2SOU EXTENSION 2 FILED—
Oct 10, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Apr 20, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 18, 2022EX1GSOU EXTENSION 1 GRANTED—
Apr 18, 2022EXT1SOU EXTENSION 1 FILED—
Apr 18, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 9, 2021NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Sep 14, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 14, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 14, 2021NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Sep 14, 2021PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Aug 26, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 26, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 26, 2021NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 11, 2021CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 4, 2021TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 3, 2021CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 3, 2021TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 11, 2021GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 11, 2021GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 11, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 4, 2021DOCKASSIGNED TO EXAMINER—
Oct 29, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Sep 24, 2020NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance